as we know, Merck and Bangs have already validated ADOs Mix&go technology and already marketed these products for months. it beckons the qns: who's next??
in e earlier threads weeks before, i've mentioned that ADO has always kind of indicated who they in talks with the names mentioned in their presentations.
this post will delve into some of these companies.
from the newest presentation:
1. Dynal - $1.15 billion (revenue)
- Following a series of mergers and acquisitions Dynal and Dynabeads are currently owned and produced by Invitrogen[4], part of Life Technologies.
2. Pall - US $2.572 Billion
- Pall Corporation is the largest manufacturer of filtration, separation, and purification products in the world. The company markets its products in four major industries: healthcare, pharmaceutical, fluid processing, and aerospace. According to the company, fluids are processed by a Pall product over 60 million times each day across the globe.
3. Millipore - revenue: $991 million USD
- In early 2010, Merck KGaA agreed to acquire all outstanding shares of Millipore's common stock, including net debt. The deal is valued at approximately EUR 5.3 billion (US$ 7.2 billion).
5. Rules based medicine http://www.rulesbasedmedicine.com/
6. Roche - $49.05 billion
- F. Hoffmann?La Roche Ltd. is a Swiss global health-care company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics.
- as we know, ADO's Dr Cummings held senior position in Roche before, a deal with Roche will put a huge rocket under ADO's sp.
7. Beckman - $3.261 billion - Beckman Coulter Inc., is a company that makes biomedical laboratory instruments.
8. Abbott - US$30.8 Billion
- Abbott's in vitro diagnostics business is a world leader in immunoassays and blood screening.
9. DiaSorin - http://www.diasorin.com/home
10. Biosite - http://www.biosite.com/
11. Qiagen - US $1.010 billion
- Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. Consolidated under the Dutch holding Qiagen N.V., the company operates more than 30 subsidiaries in over 18 countries.
12. GE healthcare -GE Healthcare has a range of products and services that include medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, and biopharmaceutical manufacturing technologies.
13. Life technologies - acquired Invitrogen and owns the dynal beads series
-Waters markets to the laboratory-dependent organization in these market areas: liquid chromatography, mass spectrometry, supercritical fluid chromatography, laboratory informatics, rheometry and microcalorimetry.
17. Agilent -US$4.48 Billion
-Agilent Technologies (NYSE: A), or Agilent, is a company which designs and manufactures electronic and bio-analytical measurement instruments and equipment for measurement and evaluation
18. ThermoFisher -$10.1 Billion
this is just a slight intro to the companies mentioned, hope that this thread can continue to discuss into some of these companies when more news come to light.
for now, there's Millipore (which already acquired by Merck) that stands out for me.
Dynal and Life technologies (same company, with different focus) = if one signs out i cant see the other not?
the thing i like about ADO is that alot of these names mentioned are huge huge companies and am sure that ADO's technology is not going to be a trick pony.
Licensing agreements will come soon and the space between each will be shorter imo. looking forward to these anns and do further research.
ADO Price at posting:
6.7¢ Sentiment: Buy Disclosure: Held
(20min delay)